1 Paules C, Subbarao K. Influenza. The Lancet. 2017;390(10095):697–708.
2 Minodier L, Charrel RN, Ceccaldi P-E, van der Werf S, Blanchon T, Hanslik T, Falchi A. Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know? Virology Journal. 2015;12:215.
3 Se vacciner contre la grippe [Internet]. Berne: Office Fédéral de la Santé Publique; c2018 [cité le 21.10.2018]. disponible à l’adresse:
https://www.sevaccinercontrelagrippe.ch/fr-ch/.
4 Belser JA, Lash RR, Garg S, Tumpey TM, Maines TR. The eyes have it: influenza virus infection beyond the respiratory tract. The Lancet Infectious Diseases 2018.
5 Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. The Lancet. 2018;391(10127):1285–300.
6 Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. New England Journal of Medicine. 2018;378(4):345–53.
7 Dugas AF, Valsamakis A, Atreya MR, Thind K, Manchego PA, Faisal A, Gaydos CA, Rothman RE. Clinical Diagnosis of Influenza in the Emergency Department. The American Journal of Emergency Medicine. 2015;33(6):770–5.
8 Yang J-H, Huang P-Y, Shie S-S, Yang S, Tsao K-C, Wu T-L, Leu H-S, Huang C-T. Predictive Symptoms and Signs of Laboratory-confirmed Influenza: A Prospective Surveillance Study of Two Metropolitan Areas in Taiwan. Medicine. 2015;94(44):e1952.
9 Qualls N, Levitt A, Kanade N, Wright-Jegede N, Dopson S, Biggerstaff M, Reed C, Uzicanin A, Group CDCCMGW. Community Mitigation Guidelines to Prevent Pandemic Influenza – United States, 2017. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. 2017;66(1):1–34.
10 Saunders-Hastings P, Crispo JAG, Sikora L, Krewski D. Effectiveness of personal protective measures in reducing pandemic influenza transmission: A systematic review and meta-analysis. Epidemics. 2017;20:1–20.
11 Seasonal Influenza Vaccine Effectiveness, 2004-2018 [Internet]. Atlanta: Centers for Disease Control and Prevention; c2018 cité le 21.10.2018]. disponible à l’adresse:
https://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm.
12 Influenza vaccine effectiveness [Internet]. Solna: European Centre for Disease Prevention and Control; c2018 cité le 21.10.2018]. disponible à l’adresse:
https://ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccine-effectiveness.
13 Saito N, Komori K, Suzuki M, Kishikawa T, Yasaka T, Ariyoshi K. Dose-Dependent Negative Effects of Prior Multiple Vaccinations Against Influenza A and Influenza B Among Schoolchildren: A Study of Kamigoto Island in Japan During the 2011–2012, 2012–2013, and 2013–2014 Influenza Seasons. Clinical Infectious Diseases. 2018:ciy202-ciy202.
14 Örtqvist Å, Brytting M, Leval A, Hergens M-P. Impact of repeated influenza vaccinations in persons over 65 years of age: A large population-based cohort study of severe influenza over six consecutive seasons, 2011/12–2016/17. Vaccine. 2018;36(37):5556–64.
15 Sarkanen TO, Alakuijala APE, Dauvilliers YA, Partinen MM. Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. Sleep Medicine Reviews. 2018;38:177–86.
16 Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. 2018;67(3):1–20.
17 Nunes MC, Cutland CL, Jones S, et al. Duration of infant protection against influenza illness conferred by maternal immunization: Secondary analysis of a randomized clinical trial. JAMA Pediatrics. 2016;170(9):840–7.
18 Heneghan CJ, Onakpoya I, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Mahtani KR, Nunan D et al. Neuraminidase inhibitors for influenza: a systematic review and meta- analysis of regulatory and mortality data. Health Technology Assessment 2016;20(42).
19 Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TSA, Al Mamun A, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. The Lancet Respiratory Medicine. 2014;2(5):395–404.
20 Ison MG. Optimizing antiviral therapy for influenza: understanding the evidence. Expert Review of Anti-infective Therapy 2015;13(4):417–25.
21 Omoto S, Speranzini V, Hashimoto T, Noshi T, Yamaguchi H, Kawai M, Kawaguchi K, Uehara T, Shishido T, Naito A, et al. Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. Scientific Reports 2018;8(1):9633.
22 Koszalka P, Tilmanis D, Hurt AC. Influenza antivirals currently in late-phase clinical trial. Influenza and Other Respiratory Viruses. 2017;11(3):240–6.
23 Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney W. Does this patient have influenza? JAMA. 2005;293(8):987–97.